P18-07. <it>Ex vivo </it>production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02) by Gallart T, Miró JM, Zamora L, Martinez-Picado J, Almela M, Pumarola T, Dalmau J, Maite G, León A, García F, Nieto S, Hurtado C, Climent N, Gil C, Gatell JM

In vivo effects of romidepsin on T-cell activation, apoptosis and function in the BCN02 HIV-1 kick&kill clinical trial by Rosás-Umbert, M, Ruiz-Riol, M, Fernández, MA, Marszalek, M, Coll, P, Manzardo, C, Cedeño, S, Miró, JM, Clotet, B, Hanke, T, Moltó, J, Mothe, B, Brander, C, BCN02 study group

Health care-associated native valve endocarditis: importance of non-nosocomial acquisition by Benito, N., Miro, J.M., de Lazzari, E., Cabell, C.H., del Rio, A., Altclas, J., Commerford, P., Delahaye, F., Dragulescu, S., Giamarellou, H., Habib, G., Kamarulzaman, A., Kumar, A.S., Nacinovich, F.M., Suter, F., Tribouilloy, C., Venugopal, K., Moreno, A., Fowler, V.G.

Therapeutic vaccination refocuses t-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study) by Mothe, B, Manzardo, C, Sanchez-Bernabeu, A, Coll, P, Morón-López, S, Puertas, MC, Rosas-Umbert, M, Cobarsi, P, Escrig, R, Perez-Alvarez, N, Ruiz, I, Rovira, C, Meulbroek, M, Crook, A, Borthwick, N, Wee, EG, Yang, H, Miró, JM, Dorrell, L, Clotet, B, Martinez-Picado, J, Brander, C, Hanke, T, BCN 01 study group

HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: Safety, immunogenicity and effect on the viral reservoir (Study BCN02) by Mothe, B, Rosás-Umbert, M, Coll, P, Manzardo, C, Puertas, MC, Morón-López, S, Llano, A, Miranda, C, Cedeño, S, López, M, Alarcón-Soto, Y, Gómez Melis, G, Langohr, K, Barriocanal, AM, Toro, J, Ruiz, I, Rovira, C, Carrillo, A, Meulbroek, M, Crook, A, Wee, EG, Miró, JM, Clotet, B, Valle, M, Martinez-Picado, J, Hanke, T, Brander, C, Moltó, J, BCN02 Study Investigators